Your Migraines Spike Around Your Period. Here's the Biological Reason.

MTHFR is the engine of your methylation cycle, the biochemical process that keeps your brain stable. It converts folate and B12 into the active forms your cells use to make neurotransmitters, regulate inflammation, and support vascular health. When this gene works well, your nervous system has the raw materials it needs to stay calm and stable.

If you carry the C677T variant, present in roughly 40% of people with European ancestry, your MTHFR enzyme runs at 40 to 70% efficiency. This means your cells struggle to convert dietary B vitamins into the active forms that prevent migraines and stabilize serotonin. You may eat enough folate and B12, but your nervous system doesn’t have access to them. Your homocysteine also rises, a compound that worsens vascular reactivity and migraine frequency.

When your estrogen drops at the start of your cycle, this deficiency becomes visible. Your brain has fewer active B vitamins to rebuild serotonin. Your blood vessels lose their ability to regulate tone smoothly. The cascade begins with a pressure sensation, then light sensitivity, then the full migraine.

SLC6A4 codes for the serotonin transporter, the gatekeeper that decides how much serotonin stays active in your synapses versus being reabsorbed and recycled. Serotonin is the neurotransmitter most tightly linked to migraine susceptibility. Low serotonin triggers the vasoconstriction and dilation cycles that produce migraine pain. Stable serotonin keeps blood vessels calm.

If you carry the short allele of the 5-HTTLPR variant, present in roughly 40% of the population, your transporter recycles serotonin more aggressively. This means serotonin doesn’t linger in your synapses long enough to stabilize your vascular and pain pathways. You’re at higher baseline risk for migraines. Add hormonal fluctuation, and your serotonin availability drops below the threshold needed to prevent migraines.

In the week before your period, when estrogen’s stabilizing effect on serotonin fades, this genetic vulnerability becomes acute. Your serotonin crashes. Blood vessels lose their regulatory control. You get a migraine reliably, often at the same cycle phase each month.

COMT breaks down dopamine and norepinephrine, neurotransmitters that regulate pain perception and stress response. When COMT works efficiently, pain signals stay proportional to actual injury. When it works slowly, pain amplification and stress sensitivity increase.

If you carry the Val158Met variant as a homozygote (two slow copies), present in roughly 25% of people with European ancestry, your COMT enzyme moves slowly. Your dopamine and norepinephrine linger in your synapses longer than they should, amplifying pain signaling in the trigeminal system, the nerve network at the core of migraine. You don’t just have migraines. You have pain amplification woven into your neurobiology.

Hormonal fluctuation compounds this. When estrogen falls, your trigeminal pain signaling becomes hyperactive without the catecholamine-mediated dampening that efficient COMT provides. Migraines become more severe and last longer. You’re also likely stress-sensitive and caffeine-reactive, which can trigger migraines or make hormonal ones worse.

AOC1, also known as DAO, is an enzyme that breaks down histamine in your gut and blood vessels. Histamine is released from mast cells during inflammation and stress, and it’s a potent trigger for migraine and vascular reactivity. When AOC1 works well, histamine gets cleared quickly. When it doesn’t, histamine accumulates and lowers your migraine threshold.

If you carry variants in AOC1, present in a significant portion of the population with ancestry in certain regions, your histamine-degrading capacity is reduced. Histamine accumulates in your bloodstream and nervous system, making your blood vessels more reactive and your pain pathways more sensitive. Foods high in histamine, stress, and hormonal transition all trigger mast cell release in someone with AOC1 variants.

Menstrual cycle, even without other vulnerabilities, triggers mast cell activation. Estrogen is a mast cell degranulator. If you also carry AOC1 variants, that degranulation floods your system with histamine right when your other migraine genes are already destabilizing. The migraine becomes severe and harder to abort.

MAOA is an enzyme that degrades serotonin, dopamine, and norepinephrine. Unlike COMT, which works slowly or quickly depending on your variant, MAOA has a different genetic structure: the number of repeats in its gene affects enzyme activity. Some people have higher activity (faster breakdown); some have lower activity (slower breakdown). Both extremes can contribute to migraine susceptibility, but for different reasons.

If you carry a low-activity MAOA variant, your monoamines linger longer in your synapses. This sounds protective for serotonin until you account for stress, hormonal transition, and the cascade of metabolic events during menstruation, when monoamine availability becomes volatile and dysregulated. Your baseline neurotransmitter tone is higher, but your stability is lower. Hormonal withdrawal feels more jarring.

During the luteal phase of your cycle, progesterone’s protective effects fade and monoamine levels fluctuate wildly. If your MAOA processes them slowly, you experience mood swings, anxiety, and migraine. The same gene variant that buffers you under stable conditions destabilizes you when hormones shift.

NOS3 produces nitric oxide in your blood vessels and brain. Nitric oxide is the master regulator of vascular tone, the signal that tells your blood vessels whether to relax or constrict. Stable nitric oxide means stable blood flow and migraine resistance. Dysregulated nitric oxide is the pathway behind migraine aura and the vasoconstriction-dilation cycles that produce migraine pain.

If you carry the Glu298Asp variant, present in roughly 30 to 40% of the population, your NOS3 enzyme produces less nitric oxide. Your blood vessels lose their ability to maintain stable, relaxed tone, making them prone to the reactive constriction and dilation that defines migraine pathophysiology. You’re at higher baseline risk for migraines, especially migraine with aura.

When estrogen falls during menstruation, nitric oxide production drops further (estrogen normally upregulates NOS3). Your cerebral and peripheral blood vessels lose their regulatory stability at exactly the moment your other genetic vulnerabilities are surfacing. The migraine, when it comes, often includes aura: visual changes, tingling, or sensory disturbances. You’re experiencing a cascading vascular and neurological event, not just pain.